ICD Cancer Research Results
ICD, immunogenic cell death (ICD): Click to Expand ⟱
| Source: |
| Type: type of cell death |
Immunogenic cell death (ICD) is a form of regulated cell death that stimulates the immune system against dying cells.
ICD is characterized by the release or exposure of specific damage‐associated molecular patterns (DAMPs) that function as “danger signals.” Key DAMPs (or ICD markers) include:
• Calreticulin (CRT) exposure
• ATP release
• High mobility group box 1 protein (HMGB1) release
• Heat shock proteins (such as HSP70 and HSP90)
• Type I interferon (IFN) responses (indirectly involved through downstream signaling)
Higher expression/exposure of ICD markers such as calreticulin, ATP, extracellular HMGB1 (with favorable redox states), HSP70/90 when released, and type I IFN responses are generally associated with enhanced antitumor immunity and improved prognosis in several cancer types.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Lung, |
H1650 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
PD-L1↑,
eff↓, The administration of N-acetyl cysteine (NAC), a reactive oxygen species (ROS) scavenger, abrogated WFA-induced ICD and PD-L1 upregulation, suggesting the involvement of ROS in this process.
ROS↑,
ER Stress↑,
Apoptosis↑,
BAX↑,
Bak↑,
BAD↑,
Bcl-2↓,
XIAP↓,
survivin↓,
cl‑PARP↑,
CHOP↑,
p‑eIF2α↑, phosphorylation of the eukaryotic initiation factor eIF-2
ICD↑,
eff↑, WFA Sensitizes LLC Syngeneic Mouse Tumors to α-PD-L1 In Vivo
OS↑, BBR could sensitize ICB to inhibit tumor growth and increased the survival rate of mice.
ROS↑,
NQO1↓,
ICD↑,
i-CRT↓, Cu(sal)phen induced the release of calreticulin (CRT), adenosine triphosphate (ATP) and high mobility group box 1 (HMGB1), the main molecular markers of ICD (immunogenic cell death)
ICD↑,
i-ATP↓,
i-HMGB1↓,
ER Stress↑, accumulation of ROS and inducing ERS
ROS↑,
DCells↑, promoted the maturation of dendritic cells (DCs)
CD8+↑, and activation of CD8+T cells
IL12↑, secretion of interleukin-12 (IL-12) and interferon-γ (IFN-γ)
IFN-γ↑,
TGF-β↓, while downregulating transforming growth factor-β (TGF-β) levels
| - |
in-vivo, |
Melanoma, |
B16-F10 |
|
|
|
Apoptosis↑, DSF/Cu + IR significantly increased the cellular apoptosis and increased ICD markers:
ICD↑,
HMGB1↑, high-mobility group box 1 (HMGB1) release, and decreased intracellular ATP levels. I
ATP↓,
TumCG↓, DSF/Cu combined with IR treatment inhibited tumor growth and enhanced tumor-infiltrating immune cells in the B16F10-bearing C57BL/6 model
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ICD↑, 4, NQO1↓, 1, ROS↑, 3,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, i-ATP↓, 1, XIAP↓, 1,
Cell Death ⓘ
Apoptosis↑, 2, BAD↑, 1, Bak↑, 1, BAX↑, 1, Bcl-2↓, 1, survivin↓, 1,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, i-CRT↓, 1, p‑eIF2α↑, 1, ER Stress↑, 2,
DNA Damage & Repair ⓘ
cl‑PARP↑, 1,
Proliferation, Differentiation & Cell State ⓘ
TumCG↓, 1,
Migration ⓘ
TGF-β↓, 1,
Immune & Inflammatory Signaling ⓘ
DCells↑, 1, HMGB1↑, 1, i-HMGB1↓, 1, IFN-γ↑, 1, IL12↑, 1, PD-L1↑, 1,
Drug Metabolism & Resistance ⓘ
eff↓, 1, eff↑, 1,
Clinical Biomarkers ⓘ
PD-L1↑, 1,
Functional Outcomes ⓘ
OS↑, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 30
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: ICD, immunogenic cell death (ICD)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1080 State#:% Dir#:2
wNotes=on sortOrder:rid,rpid
Home Page